|
No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19
JMIRx Med 2020;1(1):e19583
Go back to the top of the top articles page
Skip top articles and go to footer section
| 1005 | 8 | 1 | |
|
A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study
JMIRx Med 2020;1(1):e23582
Go back to the top of the top articles page
Skip top articles and go to footer section
| 782 | 58 | 0 | |
|
Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24453
Go back to the top of the top articles page
Skip top articles and go to footer section
| 186 | 0 | 0 | |
|
Authors’ Response to Peer Reviews of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24485
Go back to the top of the top articles page
Skip top articles and go to footer section
| 186 | 0 | 0 | |
|
Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24481
Go back to the top of the top articles page
Skip top articles and go to footer section
| 152 | 0 | 0 | |
|
Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24747
Go back to the top of the top articles page
Skip top articles and go to footer section
| 90 | 1 | 0 | |
|
Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study
JMIRx Med 2020;1(1):e22470
Go back to the top of the top articles page
Skip top articles and go to footer section
| 88 | 2 | 2 | |
|
Author Response to Peer Reviews of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24739
Go back to the top of the top articles page
Skip top articles and go to footer section
| 68 | 1 | 0 | |
|
Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24765
Go back to the top of the top articles page
Skip top articles and go to footer section
| 64 | 1 | 0 | |
|
Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis
JMIRx Med 2021;2(1):e22195
Go back to the top of the top articles page
Skip top articles and go to footer section
| 59 | 8 | 3 | |
|
Author’s Response to Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”
JMIRx Med 2020;1(1):e25573
Go back to the top of the top articles page
Skip top articles and go to footer section
| 53 | 1 | 0 | |
|
Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”
JMIRx Med 2020;1(1):e25572
Go back to the top of the top articles page
Skip top articles and go to footer section
| 43 | 1 | 0 | |
|
Authors’ Response to Peer Reviews of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27258
Go back to the top of the top articles page
Skip top articles and go to footer section
| 32 | 1 | 0 | |
|
Peer Review of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27103
Go back to the top of the top articles page
Skip top articles and go to footer section
| 22 | 1 | 1 | |
|
Peer Review of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27257
Go back to the top of the top articles page
Skip top articles and go to footer section
| 18 | 1 | 1 | |
|
A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study
JMIRx Med 2021;2(1):e22617
Go back to the top of the top articles page
Skip top articles and go to footer section
| 4 | 3 | 3 | |
|
Peer Review of “A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study”
JMIRx Med 2021;2(1):e27536
Go back to the top of the top articles page
Skip top articles and go to footer section
| 3 | 1 | 1 | |
|
Peer Review of “A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study”
JMIRx Med 2021;2(1):e27260
Go back to the top of the top articles page
Skip top articles and go to footer section
| 3 | 1 | 1 | |
|
Peer Review of “Machine Learning–Based Prediction of COVID-19 Mortality With Limited Attributes to Expedite Patient Prognosis and Triage: Retrospective Observational Study”
JMIRx Med 2021;2(4):e34082
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 0 | 0 | |
|
Peer Review of “Use of Smartphone Apps for Improving Physical Function Capacity in Cardiac Patient Rehabilitation: Systematic Review”
JMIRx Med 2021;2(3):e33181
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 0 | 0 | |
|
Peer Review of “A Full-Scale Agent-Based Model to Hypothetically Explore the Impact of Lockdown, Social Distancing, and Vaccination During the COVID-19 Pandemic in Lombardy, Italy: Model Development”
JMIRx Med 2021;2(3):e32796
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 0 | 0 | |
|
Peer Review of “Social Media Polarization and Echo Chambers in the Context of COVID-19: Case Study”
JMIRx Med 2021;2(3):e32267
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 5 | 1 | |
|
Peer Review of “Risk Factors of SARS-CoV-2 Infection: Global Epidemiological Study”
JMIRx Med 2021;2(3):e31926
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 0 | 0 | |
|
Authors’ Responses to Peer Reviews of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
JMIRx Med 2021;2(3):e31892
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 0 | 0 | |
|
Peer Review of “Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study”
JMIRx Med 2021;2(3):e31513
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |